Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer

Annals of Oncology

Volumn 25, Issue 2, 2014, Pages 352-357

  Orlandi, R ^a   De Bortoli, M ^a   Ciniselli, C M ^a   Vaghi, E ^a   Caccia, D ^a   Garrisi, V ^b   Pizzamiglio, S ^a   Veneroni, S ^a   Bonini, C ^a   Agresti, R ^a   Daidone, M G ^a   Morelli, D ^a   Camaschella, C ^c   Verderio, P ^a   Bongarzone, I ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Breast tumors; Cancer biomarker; Ferritin; Hepcidin; Iron metabolism; Plasma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FERRITIN; HEPCIDIN; HEPCIDIN 25; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; BREAST LESION; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FERRITIN BLOOD LEVEL; HEPCIDIN BLOOD LEVEL; HUMAN; LIGHT CHAIN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VERY ELDERLY; ADOLESCENT; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; EARLY DIAGNOSIS; FEMALE; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; FERRITINS; HEPCIDINS; HUMANS; MIDDLE AGED; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84893411220     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt490     Document Type: Article

References (18)

1. Kerlikowske K, Phipps AI. Breast density influences tumor subtypes and tumor aggressiveness. J Natl Cancer Inst 2011; 103: 1143-1145.
2. Hollander M, Wolfe DA. Nonparametric Statistical Methods. Second Edition, New York: John Wiley & Sons,1999.
3. Hosmer DW, Jr, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
4. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551-561.
5. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
6. Salvianti F, Pinzani P, Verderio P et al. Multiparametric analysis of cell-free DNA in melanoma patients. PLoS One 2012; 7: e49843.
7. Brown BW, Russell K. Methods of correcting for multiple testing: operating characteristics. Stat Med 1997; 16: 2511-2528.
8. Artusi R, Verderio P, Marubini E. Bravais-Pearson and Spearman correlation coefficients: meaning, test of hypothesis and confidence interval. Int J Biol Markers 2002; 17: 148-151.
9. Knovich MA, Storey JA, Coffman LG et al. Ferritin for the clinician. Blood Rev 2009; 23: 95-104.
10. Cohen LA, Gutierrez L, Weiss A et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 2010; 116: 1574-1584.
11. Alkhateeb AA, Leitzel K, Ali SM et al. Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PLoS One 2012; 7: e51379.
12. Jezequel P, Campion L, Spyratos F et al. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: a multicentric 2004 national PHRC study. Int J Cancer 2012; 131: 426-437.
13. Nemeth E, Rivera S, Gabayan V et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-1276.
14. Sharma S, Nemeth E, Chen YH et al. Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res 2008; 14: 3262-3267.
15. Maes K, Nemeth E, Roodman GD et al. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 2010; 116: 3635-3644.
16. Hohaus S, Massini G, Giachelia M et al. Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol 2010; 28: 2538-2543.
17. Pinnix ZK, Miller LD, Wang W et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med 2010; 2: 43r-56r 19.
18. Hou Y, Zhang S, Wang L et al. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 2012; 511: 398-403.